Advertisement
Advertisement
Bridion

Bridion

sugammadex

Manufacturer:

Merck Sharp & Dohme

Distributor:

Merck Sharp & Dohme
Concise Prescribing Info
Contents
Sugammadex
Indications/Uses
Reversal of rocuronium- or vecuronium-induced neuromuscular blockade in patients ≥2 yr.
Dosage/Direction for Use
Administered IV as single bolus inj. Adult Routine reversal 4 mg/kg if recovery has reached at least 1-2 post-tetanic counts (PTC) or 2 mg/kg if spontaneous recovery has occurred up to at least the reappearance of T2 following rocuronium- or vecuronium-induced blockade. Immediate reversal of rocuronium-induced blockade 16 mg/kg administered 3 min after a bolus dose of rocuronium Br 1.2 mg/kg. Re-administration Repeat dose of 4 mg/kg after an initial dose of 2 mg/kg or 4 mg/kg in exceptional situation of neuromuscular blockade post-op. Childn & adolescent 2-17 yr Routine reversal 4 mg/kg if recovery has reached at least 1-2 PTC or 2 mg/kg at reappearance of T2.
Contraindications
Hypersensitivity. Patients w/ severe renal impairment, including patients requiring dialysis (CrCl <30 mL/min).
Special Precautions
Monitor resp function during recovery/coagulation parameters in patients w/ known coagulopathies or taking anticoagulants. Recurrence of neuromuscular blockade. If rocuronium re-administration is required, 24-hr waiting time is recommended. Severe hepatic impairment. Occurrence of light anesth, in rare instances marked bradycardia; use in ICU. Not to be used for reversal of block induced by nonsteroidal neuromuscular blockers (eg, succinylcholine or benzylisoquinolinium compd) or steroidal neuromuscular blockers other than rocuronium. Displacement interactions w/ toremifene & fusidic acid. Longer recovery time in CV disease, old age or edematous state. Possibility of drug hypersensitivity reactions. Patients on controlled Na diet. Pregnancy & lactation. Childn & adolescents (immediate reversal); term newborn infants & infants.
Adverse Reactions
Airway complications (bucking against endotracheal tube, coughing, bucking, arousal reaction or contra breath), anesth complications (movement of the limb or body, coughing, grimacing or suckling on the endotracheal tube), procedural complications (coughing, tachycardia, bradycardia & increased heart rate); recurrence of neuromuscular blockade; hypersensitivity reactions; marked bradycardia.
Drug Interactions
Delayed recovery time w/ toremifene (received on the same day of the operation). May cause displacement of rocuronium w/ fusidic acid (IV). Reduced effects & effectiveness of progestogen & OC steroids (either combined or progestogen only). Interference w/ serum progesterone assay.
MIMS Class
Antidotes & Detoxifying Agents
ATC Classification
V03AB35 - sugammadex ; Belongs to the class of antidotes. Used to reverse neuromuscular blockade caused by rocuronium or vecuronium.
Presentation/Packing
Form
Bridion soln for inj 100 mg/mL
Packing/Price
2 mL x 10 × 1's (P61,089/box)
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement